Insmed Incorporated
corporate_fare Company Profile
Insmed Incorporated (NASDAQ:INSM) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 24 items for INSM at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- ARIKAYCE Phase 3b ENCORE Study Achieves Positive Topline Results, Paving Way for Label Expansion
- INSMED Reports Strong Product Revenue Growth Driven by BRINSUPRI Launch and Advances Key Pipeline Programs
- INSMED Projects Over $1 Billion in BRINSUPRI Revenue for 2026, Exceeding Expectations
- Insmed Reports Strong BRINSUPRI Launch and ARIKAYCE Performance, Announces Clinical Trial Delays
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$606.42M
Net Income
-$1.28B
Diluted EPS
-$6.42
Op. Cash Flow
-$935.01M
Free Cash Flow
-$967.58M
Gross Profit
$483.49M
Operating Income
-$1.25B
Cash & Equivalents
$510.44M
Total Debt
$540.96M
Debt / Equity
0.73×
Net Margin
-210.5%
Shares Outstanding
214.26M sh
Source: 10-K · filed 2026-02-19 · accession 0001104506-26-000009
show_chartPrice Chart
Loading chart...
feed INSM - Filings & News (Page 2)
INSM
Mar 23, 2026, 7:00 AM EDT
Price at Filing:
$140.63
Real-time Price:
$142.81
Change:
+$2.18 (+2%)
Market Cap:
$31.005B
INSM
Feb 19, 2026, 7:01 AM EST
Price at Filing:
$146.50
Real-time Price:
$142.81
Change:
-$3.69 (-3%)
Market Cap:
$31.005B
INSM
Feb 19, 2026, 7:01 AM EST
Price at Filing:
$146.50
Real-time Price:
$142.81
Change:
-$3.69 (-3%)
Market Cap:
$31.005B
INSM
Jan 09, 2026, 7:01 AM EST
Price at Filing:
$169.02
Real-time Price:
$142.81
Change:
-$26.21 (-16%)
Market Cap:
$31.005B